The Use of Antibiotic Impregnated Cement Spacers in the Treatment of Infected Total Joint Replacement: Challenges and Achievements



1 Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

2 Department of Hand-Upper Limb and Microsurgery, Hospital KAT, Athens, Greece

3 Bone and Joint Research Lab, Orthopedic Research Center, Ghaem Hospital, Mashhad, Iran


Two stage total hip arthroplasty revision surgery includes foreign material debridment, insertion of antibiotic impregnated
cement spacer, and finally, reimplantation of the prosthesis. This review has aimed to evaluate the efficacy of antibiotic
impregnated cement spacers in infection control and eradication in arthroplasties.
A total of 85 articles on total hip arthroplasty were used in this narrative literature review.
High concentrations of the antibiotic in targeted drug delivery by means of using antibiotic impregnated cement
spacers is effective against infections while reduces the side effects of systemic antibiotic therapy. This results in
prevention of bone and muscle atrophy as well as size discrepancy. Also, antibiotic impregnated cement spacers
reduce dead space and help stabilize the limb in total hip arthroplasty. Despite all reported drawbacks, antibiotic
impregnated cement spacers seem effective in eradicationg infections, although a consensus has not been yet
Level of evidence: I


Main Subjects

1. Healy WL, Della Valle CJ, Iorio R, Berend KR, Cushner
FD, Dalury DF, et al. Complications of total knee
arthroplasty: standardized list and definitions
of the Knee Society. Clin Orthop Relat Res. 2013;
2. Healy WL, Iorio R, Clair AJ, Pellegrini VD, Della Valle CJ,
Berend KR. Complications of Total Hip Arthroplasty:
Standardized List, Definitions, and Stratification
Developed by The Hip Society. Clin Orthop Relat Res.
2016; 474(2):357-64.
3. Aggarwal VK, Rasouli MR, Parvizi J. Periprosthetic
joint infection: Current concept. Indian J of Orthop.
2013; 47(1):10-7.
4. Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J.
Economic burden of periprosthetic joint infection in
the United States. J Arthroplasty. 2012; 27(8):61-5.
5. Tande AJ, Patel R. Prosthetic joint infection. Clin
Microbiol Rev. 2014; 27(2):302-45.
6. Kim YS, Bae KC, Cho CH, Lee KJ, Sohn ES, Kim BS. Two-
Stage Revision Using a Modified Articulating Spacer
in Infected Total Knee Arthroplasty. Knee Surg Relat
Res. 2013; 25(4):180-5.
7. Meek RM, Masri BA, Dunlop D, Garbuz DS, Greidanus 
NV, McGraw R, et al. Patient satisfaction and functional
status after treatment of infection at the site of a
total knee arthroplasty with use of the PROSTALAC
articulating spacer. J Bone Joint Surg Am. 2003;
8. Nelson CL. The current status of material used for
depot delivery of drugs. Clin Orthop Relat Res. 2004;
9. Romano CL, Gala L, Logoluso N, Romano D, Drago L.
Two-stage revision of septic knee prosthesis with
articulating knee spacers yields better infection
eradication rate than one-stage or two-stage revision
with static spacers. Knee Surg Sports Traumatol
Arthrosc. 2012; 20(12):2445-53.
10. Joseph TN, Chen AL, Di Cesare PE. Use of antibioticimpregnated
cement in total joint arthroplasty. J Am
Acad Orthop Surg. 2003; 11(1):38-47.
11. Hanssen AD, Spangehl MJ. Treatment of the infected
hip replacement. Clin Orthop Relat Res. 2004;
12. Pitto RP, Spika IA. Antibiotic-loaded bone cement
spacers in two-stage management of infected total
knee arthroplasty. Int Orthopa. 2004; 28(3):129-33.
13. Springer BD, Lee GC, Osmon D, Haidukewych GJ,
Hanssen AD, Jacofsky DJ. Systemic safety of high-dose
antibiotic-loaded cement spacers after resection of
an infected total knee arthroplasty. Clin Orthop Relat
Res. 2004; 427(427):47-51.
14. Anagnostakos K. Therapeutic Use of Antibiotic-loaded
Bone Cement in the Treatment of Hip and Knee Joint
Infections. J Bone Jt Infect. 2017; 2(1):29-37.
15. Soares D, Leite P, Barreira P, Aido R, Sousa R. Antibioticloaded
bone cement in total joint arthroplasty. Acta
Orthop Belg. 2015; 81(2):184-90.
16. Hanssen AD, Osmon DR, Patel R. Local antibiotic
delivery systems: where are we and where are we
going? Clin Orthop Relat Res. 2005; 437:111-4.
17. Yuenyongviwat V, Ingviya N, Pathaburee P,
Tangtrakulwanich B. Inhibitory effects of vancomycin
and fosfomycin on methicillin-resistant Staphylococcus
aureus from antibiotic-impregnated articulating
cement spacers. Bone Joint Res. 2017; 6(3):132-6.
18. Kuzyk PR, Dhotar HS, Sternheim A, Gross AE, Safir
O, Backstein D. Two-stage revision arthroplasty for
management of chronic periprosthetic hip and knee
infection: techniques, controversies, and outcomes. J
Am Acad Orthop Surg. 2014; 22(3):153-64.
19. Tsukayama DT, Goldberg VM, Kyle R. Diagnosis and
management of infection after total knee arthroplasty.
J Bone Joint Surg Am. 2003; 85:75-80.
20. Fehring TK, Odum S, Calton TF, Mason JB. Articulating
versus static spacers in revision total knee arthroplasty
for sepsis. The Ranawat Award. Clin Orthop Relat Res.
2000; 380(380):9-16.
21. Tsukayama DT, Estrada R, Gustilo RB. Infection after
total hip arthroplasty. A study of the treatment of
one hundred and six infections. J Bone Joint Surg Am.
1996; 78(4):512-23.
22. Fink B, Vogt S, Reinsch M, Buchner H. Sufficient release
of antibiotic by a spacer 6 weeks after implantation
in two-stage revision of infected hip prostheses. Clin
Orthop Relat Res. 2011; 469(11):3141-7.
23. Durbhakula SM, Czajka J, Fuchs MD, Uhl RL. Spacer
endoprosthesis for the treatment of infected total hip
arthroplasty. J Arthroplasty. 2004; 19(6):760-7.
24. Peersman G, Laskin R, Davis J, Peterson M. Infection
in total knee replacement: a retrospective review of
6489 total knee replacements. Clin Orthop Relat Res.
2001; 392:15-23.
25. Cui Q, Mihalko WM, Shields JS, Ries M, Saleh KJ.
Antibiotic-impregnated cement spacers for the
treatment of infection associated with total hip
or knee arthroplasty. J Bone Joint Surg Am. 2007;
26. Senthi S, Munro JT, Pitto RP. Infection in total hip
replacement: meta-analysis. Int Orthop. 2011;
27. Kühn KD. Management of periprosthetic joint
infection: a global perspective on diagnosis, treatment
options, prevention strategies and their economic
impact. Berlin: Springer; 2017.
28. Burnett RS, Clohisy JC, Barrack RL. Antibiotic cement
spacers in total hip and total knee arthroplasty:
problems, pitfalls, and avoiding complications. In:
Meani E, Romanò C, Crosby L, Hofmann G, Calonego
G, editors. Infection and local treatment in orthopedic
surgery. Berlin, Heidelberg: Springer Berlin
Heidelberg; 2007. P. 92-111.
29. Evans RP. Successful treatment of total hip and knee
infection with articulating antibiotic components: a
modified treatment method. Clin Orthop Relat Res.
2004; 427:37-46.
30. Duncan CP, Beauchamp C. A temporary antibioticloaded
joint replacement system for management
of complex infections involving the hip. Orthop Clin
North Am. 1993;24(4):751-9.
31. Haleem AA, Berry DJ, Hanssen AD. Mid-term to
long-term followup of two-stage reimplantation for
infected total knee arthroplasty. Clin Orthop Relat
Res. 2004; 428:35-9.
32. Barrack RL. Rush pin technique for temporary
antibiotic-impregnated cement prosthesis for
infected total hip arthroplasty. J Arthroplasty. 2002;
33. Durbhakula SM, Czajka J, Fuchs MD, Uhl RL.
Antibiotic-loaded articulating cement spacer in the
2-stage exchange of infected total knee arthroplasty.
J Arthroplasty. 2004; 19(6):768-74.
34. Chiu FY, Lin CF, Chen CM, Lo WH, Chaung TY.
Cefuroxime-impregnated cement at primary total
knee arthroplasty in diabetes mellitus. A prospective,
randomised study. J Bone Joint Surg Br. 2001;
35. Garvin KL, Hanssen AD. Infection after total hip
arthroplasty. Past, present, and future. J Bone Joint
Surg Am. 1995; 77(10):1576-88.
36. Hendriks JG, van Horn JR, van der Mei HC, Busscher
HJ. Backgrounds of antibiotic-loaded bone cement
and prosthesis-related infection. Biomaterials. 2004;
37. Thomes B, Murray P, Bouchier-Hayes D. Development
of resistant strains of Staphylococcus epidermidis on
gentamicin-loaded bone cement in vivo. J Bone Joint
Surg Br. 2002; 84(5):758-60.
38. Hope PG, Kristinsson KG, Norman P, Elson RA. Deep
infection of cemented total hip arthroplasties caused
by coagulase-negative staphylococci. J Bone Joint Surg
Br. 1989; 71(5):851-5.
39. Block JE, Stubbs HA. Reducing the risk of deep wound
infection in primary joint arthroplasty with antibiotic
bone cement. Orthopedics. 2005; 28(11):1334-45.
40. Roberts AR. The safety of high-dose antibiotic cement
spacers in the two-stage revision of infected total
joint arthroplasty. 2016.
41. Armstrong MS, Spencer RF, Cunningham JL, Gheduzzi
S, Miles AW, Learmonth ID. Mechanical characteristics
of antibiotic-laden bone cement. Acta Orthop Scand.
2002; 73(6):688-90.
42. Stewart PS. Mechanisms of antibiotic resistance
in bacterial biofilms. Int J Med Microbiol. 2002;
43. Lu CL, Liu CY, Huang YT, Liao CH, Teng LJ, Turnidge
JD, et al. Antimicrobial susceptibilities of commonly
encountered bacterial isolates to fosfomycin
determined by agar dilution and disk diffusion 
methods. Antimicrob Agents Chemother. 2011;
44. Jacofsky DJ, Della Valle CJ, Meneghini RM, Sporer SM,
Cercek RM. Revision total knee arthroplasty: what the
practicing orthopaedic surgeon needs to know. Instr
Course Lect. 2011;60:269-81.
45. Hsieh PH, Chen LH, Chen CH, Lee MS, Yang WE, Shih CH.
Two-stage revision hip arthroplasty for infection with
a custom-made, antibiotic-loaded, cement prosthesis
as an interim spacer. J Trauma. 2004; 56(6):1247-52.
46. Kaminski A, Citak M, Schildhauer TA, Fehmer T.
Success rates for initial eradication of peri-prosthetic
knee infection treated with a two-stage procedure.
Ortop Traumatol Rehabil. 2014; 16(1):11-6.
47. Volin SJ, Hinrichs SH, Garvin KL. Two-stage
reimplantation of total joint infections: a comparison
of resistant and non-resistant organisms. Clin Orthop
Relat Res. 2004; 427:94-100.
48. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint
infections. N Engl J Med. 2004; 351(16):1645-54.
49. Micozzi A, Nucci M, Venditti M, Gentile G, Girmenia
C, Meloni G, et al. Piperacillin/tazobactam/amikacin
versus piperacillin/amikacin/teicoplanin in the
empirical treatment of neutropenic patients. Eur J
Clin Microbiol Infect Dis. 1993; 12(1):1-8.
50. Paz E, Sanz-Ruiz P, Abenojar J, Vaquero-Martin J, Forriol
F, Del Real JC. Evaluation of Elution and Mechanical
Properties of High-Dose Antibiotic-Loaded Bone
Cement: Comparative “In Vitro” Study of the Influence
of Vancomycin and Cefazolin. J Arthroplasty. 2015;
51. Chang Y, Chen WC, Hsieh PH, Chen DW, Lee MS, Shih HN,
et al. In vitro activities of daptomycin-, vancomycin-, and
teicoplanin-loaded polymethylmethacrylate against
methicillin-susceptible, methicillin-resistant, and
vancomycin-intermediate strains of Staphylococcus
aureus. Antimicrob Agents Chemother. 2011;
52. Roth KE, Krause B, Siegel E, Maier G, Schoellner C,
Rommens PM. Liquid dextran does not increase the
elution rate of different antibiotics from bone cement.
Eur J Orthop Surg Traumatol. 2015; 25(1):83-9.
53. Samuel S, Mathew BS, Veeraraghavan B, Fleming DH,
Chittaranjan SB, Prakash JA. In vitro study of elution
kinetics and bio-activity of meropenem-loaded acrylic
bone cement. J Orthop Traumatol. 2012; 13(3):131-6.
54. Anagnostakos K, Kelm J, Regitz T, Schmitt E, Jung W. In
vitro evaluation of antibiotic release from and bacteria
growth inhibition by antibiotic-loaded acrylic bone
cement spacers. J Biomed Mater Res B Appl Biomater.
2005; 72(2):373-8.
55. Baleani M, Persson C, Zolezzi C, Andollina A, Borrelli
AM, Tigani D. Biological and biomechanical effects of
vancomycin and meropenem in acrylic bone cement. J
Arthroplasty. 2008; 23(8):1232-8.
56. Koo KH, Yang JW, Cho SH, Song HR, Park HB, Ha
YC, et al. Impregnation of vancomycin, gentamicin,
and cefotaxime in a cement spacer for two-stage
cementless reconstruction in infected total hip
arthroplasty. J Arthroplasty. 2001; 16(7):882-92.
57. Park SJ, Song EK, Seon JK, Yoon TR, Park GH.
Comparison of static and mobile antibioticimpregnated
cement spacers for the treatment of
infected total knee arthroplasty. Int Orthop. 2010;
58. Huddleston PM, Steckelberg JM, Hanssen AD, Rouse
MS, Bolander ME, Patel R. Ciprofloxacin inhibition of
experimental fracture healing. J Bone Joint Surg Am.
2000; 82(2):161-73.
59. Shridhar P, Chen Y, Khalil R, Plakseychuk A, Cho SK,
Tillman B, et al. A Review of PMMA Bone Cement and
Intra-Cardiac Embolism. Materials (Basel). 2016;
60. Elahpour N, Rabiee SM, Ebrahimzadeh MH, Moradi
A. In-vitro formation and growth kinetics of
apatite on a new light-cured composite calcium
phosphate cement. Ceramics International. 2018;
61. Dion A, Berno B, Hall G, Filiaggi MJ. The effect of
processing on the structural characteristics of
vancomycin-loaded amorphous calcium phosphate
matrices. Biomaterials. 2005; 26(21):4486-94.
62. Jiranek WA, Hanssen AD, Greenwald AS. Antibioticloaded
bone cement for infection prophylaxis in
total joint replacement. J Bone Joint Surg Am. 2006;
63. Alt V, Bechert T, Steinrücke P, Wagener M, Seidel P,
Dingeldein E, et al. In Vitro Testing of Antimicrobial
Activity of Bone Cement. Antimicrobial Agents
Chemother. 2004; 48(11):4084-8.
64. Chiang ER, Su YP, Chen TH, Chiu FY, Chen WM.
Comparison of articulating and static spacers
regarding infection with resistant organisms in total
knee arthroplasty. Acta Orthop. 2011; 82(4):460-4.
65. Emerson RH, Jr., Muncie M, Tarbox TR, Higgins LL.
Comparison of a static with a mobile spacer in total
knee infection. Clin Orthop Relat Res. 2002; 404:132-8.
66. Hsieh PH, Chang YH, Chen SH, Ueng SW, Shih CH. High
concentration and bioactivity of vancomycin and
aztreonam eluted from Simplex cement spacers in
two-stage revision of infected hip implants: a study
of 46 patients at an average follow-up of 107 days. J
Orthop Res. 2006; 24(8):1615-21.
67. Rogers BA, Middleton FR, Shearwood-Porter N, Kinch
S, Roques A, Bradley NW, et al. Does cyclical loading
affect the elution of antibiotics from articulating
cement knee spacers? J Bone Joint Surg Br. 2011;
68. Salih S, Paskins A, Nichol T, Smith T, Hamer A. The
cement spacer with multiple indentations: increasing
antibiotic elution using a cement spacer ‘teabag’. Bone
Joint J. 2015; 97-b(11):1519-24.
69. Klekamp J, Dawson JM, Haas DW, DeBoer D, Christie
M. The use of vancomycin and tobramycin in acrylic
bone cement: biomechanical effects and elution
kinetics for use in joint arthroplasty. J Arthroplasty.
1999; 14(3):339-46.
70. Askew MJ, Kufel MF, Fleissner PR Jr, Gradisar IA Jr,
Salstrom SJ, Tan JS. Effect of vacuum mixing on the
mechanical properties of antibiotic-impregnated
polymethylmethacrylate bone cement. J Biomed
Mater Res. 1990; 24(5):573-80.
71. Kuehn KD, Ege W, Gopp U. Acrylic bone cements:
mechanical and physical properties. Orthop Clin
North Am. 2005; 36(1):29-39.
72. Lewis G, Janna S. The in vitro elution of gentamicin
sulfate from a commercially available gentamicinloaded
acrylic bone cement, VersaBond™ AB. J Biomed
Mater Res B Appl Biomater. 2004; 71(1):77-83.
73. Neut D, van de Belt H, van Horn JR, van der Mei HC,
Busscher HJ. The effect of mixing on gentamicin
release from polymethylmethacrylate bone cements.
Acta Orthop Scand. 2003; 74(6):670-6.
74. Kuechle DK, Landon GC, Musher DM, Noble PC. Elution
of vancomycin, daptomycin, and amikacin from acrylic
bone cement. Clin Orthop Relat Res. 1991; 264:302-8.
75. Elson RA, Jephcott AE, McGechie DB, Verettas D.
Antibiotic-loaded acrylic cement. J Bone Joint Surg Br.
1977; 59(2):200-5.
76. Ries MD, Jergesen H. An inexpensive molding
method for antibiotic-impregnated cement spacers
in infected total hip arthroplasty. J Arthroplasty.
1999; 14(6):764-5.
77. Stevens CM, Tetsworth KD, Calhoun JH, Mader JT. An
articulated antibiotic spacer used for infected total
knee arthroplasty: a comparative in vitro elution
study of Simplex and Palacos bone cements. J Orthop
Res. 2005; 23(1):27-33.
78. Bertazzoni Minelli E, Benini A, Magnan B, Bartolozzi
P. Release of gentamicin and vancomycin from
temporary human hip spacers in two-stage revision
of infected arthroplasty. J Antimicrob Chemother.
2004; 53(2):329-34.
79. Kelm J, Regitz T, Schmitt E, Jung W, Anagnostakos K. In 
vivo and in vitro studies of antibiotic release from and
bacterial growth inhibition by antibiotic-impregnated
polymethylmethacrylate hip spacers. Antimicrob
Agents Chemother. 2006; 50(1):332-5.
80. Jung J, Schmid NV, Kelm J, Schmitt E, Anagnostakos
K. Complications after spacer implantation in the
treatment of hip joint infections. Int J Med Sci. 2009;
6(5): 265–273.
81. Hsieh PH, Huang KC, Tai CL. Liquid gentamicin in
bone cement spacers: in vivo antibiotic release and
systemic safety in two-stage revision of infected hip
arthroplasty. J Trauma. 2009; 66(3):804-8.
82. Dovas S, Liakopoulos V, Papatheodorou L,
Chronopoulou I, Papavasiliou V, Atmatzidis E, et
al. Acute renal failure after antibiotic-impregnated
bone cement treatment of an infected total knee
arthroplasty. Clin Nephrol. 2008; 69(3):207-12.
83. Goldstein WM, Kopplin M, Wall R, Berland K.
Temporary articulating methylmethacrylate antibiotic
spacer (TAMMAS). A new method of intraoperative
manufacturing of a custom articulating spacer. J Bone
Joint Surg Am. 2001; 83:92-7.
84. Wentworth SJ, Masri BA, Duncan CP, Southworth CB.
Hip prosthesis of antibiotic-loaded acrylic cement
for the treatment of infections following total hip
arthroplasty. J Bone Joint Surg Am. 2002; 84:123-8.
85. Haddad FS, Masri BA, Campbell D, McGraw RW,
Beauchamp CP, Duncan CP. The PROSTALAC functional
spacer in two-stage revision for infected knee
replacements. Prosthesis of antibiotic-loaded acrylic
cement. J Bone Joint Surg Br. 2000; 82(6):807-12.